Literature DB >> 28763613

The Importance of Mitophagy in Maintaining Mitochondrial Function in U373MG Cells. Bafilomycin A1 Restores Aminochrome-Induced Mitochondrial Damage.

Sandro Huenchuguala1, Patricia Muñoz1, Juan Segura-Aguilar1.   

Abstract

Aminochrome, an orthoquinone formed during the dopamine oxidation of neuromelanin, is neurotoxic because it induces mitochondria dysfunction, protein degradation dysfunction (both autophagy and proteasomal systems), α-synuclein aggregation to neurotoxic oligomers, neuroinflammation, and oxidative and endoplasmic reticulum stress. In this study, we investigated the relationship between aminochrome-induced autophagy/lysosome dysfunction and mitochondrial dysfunction in U373MGsiGST6 cells. Aminochrome (75 μM) induces mitochondrial dysfunction as determined by (i) a significant decrease in ATP levels (70%; P < 0.001) and (ii) a significant decrease in mitochondrial membrane potential (P < 0.001). Interestingly, the pretreatment of U373MGsiGST6 cells with 100 nM bafilomycin-A1, an inhibitor of lysosomal vacuolar-type H+-ATPase, restores ATP levels, mitochondrial membrane potential, and mitophagy, and decreases cell death. These results reveal (i) the importance of macroautophagy/the lysosomal degradation system for the normal functioning of mitochondria and for cell survival, and (ii) aminochrome-induced lysosomal dysfunction depends on the aminochrome-dependent inactivation of the vacuolar-type H+-ATPase, which pumps protons into the lysosomes. This study also supports the proposed protective role of glutathione transferase mu2-2 (GSTM2) in astrocytes against aminochrome toxicity, mediated by mitochondrial and lysosomal dysfunction.

Entities:  

Keywords:  Aminochrome; Astrocytes; Dopamine; Glutathione transferase; Lysosome dysfunction; Mitochondria; Mitophagy

Mesh:

Substances:

Year:  2017        PMID: 28763613     DOI: 10.1021/acschemneuro.7b00152

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  12 in total

Review 1.  Neurotoxins as Preclinical Models for Parkinson's Disease.

Authors:  Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2018-01-08       Impact factor: 3.911

2.  Comment on: "Activating Autophagy as a Therapeutic Strategy for Parkinson's Disease".

Authors:  Juan Segura-Aguilar
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

Review 3.  Dopamine: Functions, Signaling, and Association with Neurological Diseases.

Authors:  Marianne O Klein; Daniella S Battagello; Ariel R Cardoso; David N Hauser; Jackson C Bittencourt; Ricardo G Correa
Journal:  Cell Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.046

4.  Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson's Disease.

Authors:  Fillipe Mendes De Araújo; Annyta Fernandes Frota; Lívia Bacelar de Jesus; Ticiane Caribe Macedo; Lorena Cuenca-Bermejo; Consuelo Sanchez-Rodrigo; Kariny Maria Silva Ferreira; Juciele Valéria Ribeiro de Oliveira; Maria de Fatima Dias Costa; Juan Segura-Aguilar; Silvia Lima Costa; Maria Trinidad Herrero; Victor Diógenes Amaral Silva
Journal:  Cell Mol Neurobiol       Date:  2022-01-06       Impact factor: 5.046

5.  Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease.

Authors:  David Sulzer; Fabio A Zucca; Luigi Zecca
Journal:  Clin Pharmacol Transl Med       Date:  2019-05-06

6.  Novel Alpha-Synuclein Oligomers Formed with the Aminochrome-Glutathione Conjugate Are Not Neurotoxic.

Authors:  Sandro Huenchuguala; Birgitta Sjödin; Bengt Mannervik; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2018-10-20       Impact factor: 3.911

7.  Cellular Trafficking of Glutathione Transferase M2-2 Between U373MG and SHSY-S7 Cells is Mediated by Exosomes.

Authors:  Raúl Valdes; Alicia Armijo; Patricia Muñoz; Kjell Hultenby; Andres Hagg; Jose Inzunza; Ivan Nalvarte; Mukesh Varshney; Bengt Mannervik; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2021-02-08       Impact factor: 3.911

8.  Aminochrome Induces Irreversible Mitochondrial Dysfunction by Inducing Autophagy Dysfunction in Parkinson's Disease.

Authors:  Juan Segura-Aguilar; Sandro Huenchuguala
Journal:  Front Neurosci       Date:  2018-03-13       Impact factor: 4.677

9.  Study on the Mechanism of Liuwei Dihuang Pills in Treating Parkinson's Disease Based on Network Pharmacology.

Authors:  Dongtao Lin; Yudan Zeng; Deyu Tang; Yongming Cai
Journal:  Biomed Res Int       Date:  2021-10-28       Impact factor: 3.411

10.  Transcriptome analysis reveals mechanism underlying the differential intestinal functionality of laying hens in the late phase and peak phase of production.

Authors:  Wei-Wei Wang; Jing Wang; Hai-Jun Zhang; Shu-Geng Wu; Guang-Hai Qi
Journal:  BMC Genomics       Date:  2019-12-12       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.